Episode

Circulation February 24, 2026 Issue

Podcast: Circulation on the Run
Published: Feb 23, 2026
Duration seconds: 2137
Processing state: not_requested
Canonical source: https://circulation.libsyn.com/circulation-february-24-2026-issue
Audio: https://dts.podtrac.com/redirect.mp3/traffic.libsyn.com/secure/circulation/COTR153_08_master.mp3?dest-id=376443
JSON: /v1/public/podcasts/circulation-on-the-run-1003485/episodes/circulation-february-24-2026-issue
Markdown: /podcast/circulation-on-the-run-1003485/circulation-february-24-2026-issue.md

Actions

POST https://stenobird.com/v1/public/podcasts/circulation-on-the-run-1003485/episodes/circulation-february-24-2026-issue/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/circulation-on-the-run-1003485/circulation-february-24-2026-issue.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

This week, join author Moritz J. Hundertmark and Associate Editor Vlad Zaha as they discuss their article "IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes." For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260223.163027